meta_pixel
Tapesearch Logo
Log in
Global News Podcast

New Alzheimer's drug hailed a 'miracle'

Global News Podcast

BBC

News, Daily News

4.38.3K Ratings

🗓️ 17 July 2023

⏱️ 28 minutes

🧾️ Download transcript

Summary

A large trial has confirmed the drug, Donanemab, slows cognitive decline by a-third. Also: Working From Anywhere - the trend taking off in offices across the world, and the 80-year-old who's finally going into space.

Transcript

Click on a timestamp to play from that location

0:00.0

This is the Global News Podcast from the BBC World Service.

0:06.0

I'm Kashmadiya, and in the early hours of the 18th of July,

0:09.6

these are our main stories.

0:11.8

Scientists have hailed a new Alzheimer's drug

0:14.5

a turning point in the fight against the disease.

0:17.8

China's registered a record high temperature

0:20.8

as the US climate envoy visits Beijing

0:23.3

to press for greater efforts to tackle global warming.

0:27.4

The UN Secretary-General has led international condemnation

0:30.9

of a decision by Russia to end the deal to export grain from Ukraine.

0:39.0

Also coming up in this podcast,

0:40.8

a hard day's work in the office.

0:49.2

Working from anywhere the trend taking off in offices across the world.

0:58.3

Hello and welcome.

0:59.5

In our earlier podcast,

1:00.9

we heard that scientists were keenly awaiting the release

1:03.9

of final test results from a new drug to treat Alzheimer's disease.

1:09.3

Don Anabad has been hailed as a miracle drug

1:12.6

which will usher in a new era for dementia sufferers.

1:16.3

While the publication of the test results has confirmed the predictions,

1:20.2

the drug can slow down the decline of brainpower by a third

1:24.3

among those who are treated early enough.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from BBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of BBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.